Sources | Names Used |
---|---|
CCLE, GDSC1000, gCSI | MDA-MB-231 |
GRAY, FIMM, CTRPv2 | MDAMB231 |
UHNBreast | mdamb231 |
PharmacoGx | MDA-MB-231 |
NCIt, C5214, Breast adenocarcinoma
GSK1838705 | GRAY | 8 |
paclitaxel | gCSI, GRAY, FIMM, CTRPv2, UHNBreast | 8 |
Bortezomib | gCSI, GRAY, FIMM, CTRPv2 | 8 |
Erlotinib | gCSI, GRAY, FIMM, CTRPv2, UHNBreast | 7 |
Vorinostat | GDSC1000, gCSI, GRAY, FIMM, CTRPv2 | 7 |
Gefitinib | GDSC1000, GRAY, FIMM, CTRPv2 | 7 |
Doxorubicin | GDSC1000, gCSI, GRAY, FIMM, CTRPv2 | 7 |
lapatinib | gCSI, GRAY, FIMM, CTRPv2 | 6 |
Methotrexate | GDSC1000, GRAY, FIMM, CTRPv2 | 6 |
AZD6244 | GDSC1000, GRAY, FIMM, CTRPv2 | 6 |